The global market for Interventional Radiology Systems is estimated at US$25.1 Billion in 2023 and is projected to reach US$40.6 Billion by 2030, growing at a CAGR of 7.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the interventional radiology systems market is driven by several factors. The increasing prevalence of chronic diseases such as cardiovascular disorders and cancer is a significant driver, as minimally invasive treatments become a preferred option. Technological advancements in imaging and navigation systems are enabling more precise and effective procedures. The rising demand for minimally invasive surgeries, which offer reduced recovery times and lower risk of complications, is also contributing to market growth. Additionally, the growing aging population and the associated increase in age-related conditions are fueling the demand for interventional radiology. The integration of AI and machine learning in imaging systems is enhancing diagnostic accuracy and procedural outcomes, further driving the adoption of these advanced systems.
The growth in the interventional radiology systems market is driven by several factors. The increasing prevalence of chronic diseases such as cardiovascular disorders and cancer is a significant driver, as minimally invasive treatments become a preferred option. Technological advancements in imaging and navigation systems are enabling more precise and effective procedures. The rising demand for minimally invasive surgeries, which offer reduced recovery times and lower risk of complications, is also contributing to market growth. Additionally, the growing aging population and the associated increase in age-related conditions are fueling the demand for interventional radiology. The integration of AI and machine learning in imaging systems is enhancing diagnostic accuracy and procedural outcomes, further driving the adoption of these advanced systems.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the MRI Systems segment, which is expected to reach US$12.7 Billion by 2030 with a CAGR of a 8.2%. The Ultrasound Imaging Systems segment is also set to grow at 7.3% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $7.6 Billion in 2023, and China, forecasted to grow at an impressive 9.2% CAGR to reach $4.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Interventional Radiology Systems Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Interventional Radiology Systems Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Interventional Radiology Systems Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Laboratories, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 92 Featured):
- Abbott Laboratories, Inc.
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Barco NV
- Agfa-Gevaert NV
- Analogic Corporation
- AngioDynamics, Inc.
- Biosensors International Group Ltd.
- Allengers Medical Systems Ltd.
- Aurora Imaging Technology, Inc.
- Animage, LLC
- Beijing Wandong Medical Technology Co., Ltd.
- Arrays Medical Imaging Corporation
- Amolab srl
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAFRANCEITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned
- Abbott Laboratories, Inc.
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Barco NV
- Agfa-Gevaert NV
- Analogic Corporation
- AngioDynamics, Inc.
- Biosensors International Group Ltd.
- Allengers Medical Systems Ltd.
- Aurora Imaging Technology, Inc.
- Animage, LLC
- Beijing Wandong Medical Technology Co., Ltd.
- Arrays Medical Imaging Corporation
- Amolab srl
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 500 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 25.1 Billion |
| Forecasted Market Value ( USD | $ 40.6 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
